These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 7879046)
21. 15-Deoxyspergualin potentiates the immunosuppressive effect of cyclosporine A in a rat heart allograft model. Gannedahl G; Wanders A; Carlsson M; Tufveson G Transplant Proc; 1993 Feb; 25(1 Pt 1):768-9. PubMed ID: 8438473 [No Abstract] [Full Text] [Related]
22. Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat. Knoop M; Cramer DV; Chapman FC; Makowka L Transplant Proc; 1993 Feb; 25(1 Pt 1):706-7. PubMed ID: 8438447 [No Abstract] [Full Text] [Related]
23. Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxazol derivative. Schorlemmer HU; Seiler FR; Bartlett RR Transplant Proc; 1993 Feb; 25(1 Pt 1):763-7. PubMed ID: 8438472 [No Abstract] [Full Text] [Related]
25. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506. D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476 [No Abstract] [Full Text] [Related]
26. CD4-targeted therapy induces "infectious" tolerance to cardiac allografts in sensitized rat recipients. Onodera K; Lehmann M; Volk HD; Sayegh MH; Kupiec-Weglinski JW Transplant Proc; 1997 May; 29(3):1907-8. PubMed ID: 9142316 [No Abstract] [Full Text] [Related]
27. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation. Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031 [TBL] [Abstract][Full Text] [Related]
29. Beneficial effects of monoclonal antibody targeting of CD4+ cells during the sensitisation but not effector phase of accelerated rejection of rat cardiac allografts. Hancock WW; Sablinski T; Milford EL; Tilney NL; Atkins RC; Kupiec-Weglinski JW Transplant Proc; 1990 Oct; 22(5):2115-6. PubMed ID: 2219313 [No Abstract] [Full Text] [Related]
30. Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in the rat. Nagamine S; Ohmi M; Tabayashi K; Iguchi A; Mohri H J Heart Lung Transplant; 1994; 13(5):895-8. PubMed ID: 7803433 [TBL] [Abstract][Full Text] [Related]
31. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model. Hamashima T; Yoshimura N; Ohsaka Y; Oka T; Stepkowski SM; Kahan BD Transplant Proc; 1993 Feb; 25(1 Pt 1):723-4. PubMed ID: 8438457 [No Abstract] [Full Text] [Related]
32. 15-Deoxyspergualin inhibits antibody production in mouse to rat heart transplantation. Gannedahl G; Karlsson-Parra A; Tötterman TH; Tufveson G Transplant Proc; 1993 Feb; 25(1 Pt 1):778-80. PubMed ID: 8438478 [No Abstract] [Full Text] [Related]
33. Donor-type blood and immunoadjuvant-induced accelerated cardiac allograft rejection: a rat model. Takahara S; Jiang H; Takano Y; Kameoka H; Kokado Y; Ishibashi M; Jiang Y; Moutabarrik A; Okuyama A; Sonoda T Transplant Proc; 1992 Oct; 24(5):1659-60. PubMed ID: 1412787 [No Abstract] [Full Text] [Related]
34. Effect of 15-deoxyspergualin on rejection detected by 31P nuclear magnetic resonance spectroscopy and in vivo mechanisms of action in rat heart transplantation. Suzuki S; Kanashiro M; Watanabe H; Sakakibara I; Amemiya H Transplant Proc; 1989 Feb; 21(1 Pt 1):1094-5. PubMed ID: 2523115 [No Abstract] [Full Text] [Related]
35. Gemcitabine in models of acute and accelerated rejection. Jung F; Wilker S; Maas E; Brendel MD; Grimm H; Korom S Transplant Proc; 2002 Aug; 34(5):1420-1. PubMed ID: 12176422 [No Abstract] [Full Text] [Related]
36. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat. Knoop M; Cramer DV; Chapman FC; Makowka L Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719 [No Abstract] [Full Text] [Related]
37. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients. Wasowska B; Wieder KJ; Hancock WW; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW Transplant Proc; 1995 Feb; 27(1):423-6. PubMed ID: 7879047 [No Abstract] [Full Text] [Related]
38. Sensitization interval and administration method alter the effect of 15-deoxyspergualin on heart transplantation in sensitized recipient rats. Ueda H; Itoh S; Iwamoto Y; Takasaki N Transpl Int; 1996; 9(6):551-6. PubMed ID: 8914234 [TBL] [Abstract][Full Text] [Related]
39. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions. Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895 [TBL] [Abstract][Full Text] [Related]
40. Cellular basis of immunologic tolerance following total bowel transplantation in rats. II. Dominant role of suppressor T cells in adoptive transfer of acquired tolerance to vascularized allografts. Masaki Y; Oohara T; Shinomiya T; Kimura H Transplant Proc; 1995 Apr; 27(2):1589-92. PubMed ID: 7536972 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]